82 related articles for article (PubMed ID: 3215211)
1. Free drug levels monitoring as a detector of false metabolic refractory epilepsy.
Gianelli M; Gentile S; Verzè L; Dimanico U; Baruchello M; Monaco F; Mutani R
Eur Neurol; 1988; 28(6):349-53. PubMed ID: 3215211
[TBL] [Abstract][Full Text] [Related]
2. Phenobarbital pharmacokinetics in old age: a case-matched evaluation based on therapeutic drug monitoring data.
Messina S; Battino D; Croci D; Mamoli D; Ratti S; Perucca E
Epilepsia; 2005 Mar; 46(3):372-7. PubMed ID: 15730534
[TBL] [Abstract][Full Text] [Related]
3. Effects of CYP3A4/5 and ABCB1 genetic polymorphisms on carbamazepine metabolism and transport in Chinese patients with epilepsy treated with carbamazepine in monotherapy and bitherapy.
Wang P; Yin T; Ma HY; Liu DQ; Sheng YH; Wang C; Zhou BT
Epilepsy Res; 2015 Nov; 117():52-7. PubMed ID: 26421491
[TBL] [Abstract][Full Text] [Related]
4. Serum carbamazepine concentrations in elderly patients: a case-matched pharmacokinetic evaluation based on therapeutic drug monitoring data.
Battino D; Croci D; Rossini A; Messina S; Mamoli D; Perucca E
Epilepsia; 2003 Jul; 44(7):923-9. PubMed ID: 12823575
[TBL] [Abstract][Full Text] [Related]
5. Steady state pharmacokinetics of carbamazepine-phenobarbital interaction in patients with epilepsy.
Sennoune S; Iliadis A; Bonneton J; Barra Y; Genton P; Mesdjian E
Biopharm Drug Dispos; 1996 Mar; 17(2):155-64. PubMed ID: 8907722
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of anticonvulsants in pregnancy: alterations in plasma protein binding.
Yerby MS; Friel PN; McCormick K; Koerner M; Van Allen M; Leavitt AM; Sells CJ; Yerby JA
Epilepsy Res; 1990 Apr; 5(3):223-8. PubMed ID: 2384078
[TBL] [Abstract][Full Text] [Related]
7. Daily salivary anticonvulsant monitoring in patients with intractable epilepsy.
Herkes GK; Eadie MJ
Clin Exp Neurol; 1989; 26():141-9. PubMed ID: 2642124
[TBL] [Abstract][Full Text] [Related]
8. Population pharmacokinetics of carbamazepine in Singapore epileptic patients.
Chan E; Lee HS; Hue SS
Br J Clin Pharmacol; 2001 Jun; 51(6):567-76. PubMed ID: 11422016
[TBL] [Abstract][Full Text] [Related]
9. Vitamin D levels and bone turnover in epilepsy patients taking carbamazepine or oxcarbazepine.
Mintzer S; Boppana P; Toguri J; DeSantis A
Epilepsia; 2006 Mar; 47(3):510-5. PubMed ID: 16529614
[TBL] [Abstract][Full Text] [Related]
10. Factors influencing topiramate clearance in adult patients with epilepsy: A population pharmacokinetic analysis.
Bae EK; Lee J; Shin JW; Moon J; Lee KJ; Shin YW; Kim TJ; Shin D; Jang IJ; Lee SK
Seizure; 2016 Apr; 37():8-12. PubMed ID: 26908152
[TBL] [Abstract][Full Text] [Related]
11. Population pharmacokinetic modelling of carbamazepine in epileptic elderly patients: implications for dosage.
Bondareva IB; Jelliffe RW; Gusev EI; Guekht AB; Melikyan EG; Belousov YB
J Clin Pharm Ther; 2006 Jun; 31(3):211-21. PubMed ID: 16789986
[TBL] [Abstract][Full Text] [Related]
12. Implications of metabolic parameters of carbamazepine in the therapeutic monitoring of Tunisian patients with epilepsy.
Chbili C; Hassine A; Ben Amor S; Nouira M; Ben Ammou S; Saguem S
Rev Neurol (Paris); 2016; 172(4-5):313-7. PubMed ID: 27062293
[TBL] [Abstract][Full Text] [Related]
13. Population pharmacokinetics of steady-state carbamazepine in Egyptian epilepsy patients.
El Desoky ES; Sabarinath SN; Hamdi MM; Bewernitz M; Derendorf H
J Clin Pharm Ther; 2012 Jun; 37(3):352-5. PubMed ID: 21883329
[TBL] [Abstract][Full Text] [Related]
14. Nonlinear mixed effects modelling approach in investigating phenobarbital pharmacokinetic interactions in epileptic patients.
Vučićević K; Jovanović M; Golubović B; Kovačević SV; Miljković B; Martinović Ž; Prostran M
Eur J Clin Pharmacol; 2015 Feb; 71(2):183-90. PubMed ID: 25380628
[TBL] [Abstract][Full Text] [Related]
15. [Optimisation of epilepsy monotherapy (clinico-pharmacological study)].
Gromov SA; Khorshev SK
Zh Nevrol Psikhiatr Im S S Korsakova; 1997; 97(7):31-5. PubMed ID: 9511212
[TBL] [Abstract][Full Text] [Related]
16. Carbamazepine clearance and seizure stability during pregnancy.
Johnson EL; Stowe ZN; Ritchie JC; Newport DJ; Newman ML; Knight B; Pennell PB
Epilepsy Behav; 2014 Apr; 33():49-53. PubMed ID: 24632353
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of therapeutic drug monitoring of antiepileptic drugs.
Irshaid YM; Hamdi AA; Al Homrany M
Int J Clin Pharmacol Ther; 2003 Mar; 41(3):126-31. PubMed ID: 12665161
[TBL] [Abstract][Full Text] [Related]
18. Factors influencing carbamazepine pharmacokinetics in children and adults: population pharmacokinetic analysis.
Milovanovic JR; Jankovic SM
Int J Clin Pharmacol Ther; 2011 Jul; 49(7):428-36. PubMed ID: 21726493
[TBL] [Abstract][Full Text] [Related]
19. Antiepileptic TDM pattern at a tertiary care hospital in India.
Jose VM; Medhi B; Pandhi P
Nepal Med Coll J; 2006 Jun; 8(2):107-10. PubMed ID: 17017400
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic interactions of carbamazepine with some antiepileptic drugs during epilepsy treatment in children and adolescents.
Steinborn B
Rocz Akad Med Bialymst; 2005; 50 Suppl 1():9-15. PubMed ID: 16119616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]